Retinal diseases are one of the leading causes of blindness globally. The mainstay treatments for these blinding diseases are laser photocoagulation, vitrectomy, and repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) or steroids. Unfortunately, these therapies are associated with ocular complications like inflammation, elevated intraocular pressure, retinal detachment, endophthalmitis, and vitreous hemorrhage. Recent advances in nanomedicine seek to curtail these limitations, overcoming ocular barriers by developing non-invasive or minimally invasive delivery modalities. These modalities include delivering therapeutics to specific cellular targets in the retina, providing sustained delivery of drugs to avoid repeated intravitreal injections, and acting as a scaffold for neural tissue regeneration. These next-generation nanomedicine approaches could potentially revolutionize the treatment landscape of retinal diseases. This review describes the availability and limitations of current treatment strategies and highlights insights into the advancement of future approaches using next-generation nanomedicines to manage retinal diseases.
A simple, portable, economical lowtemperature atmospheric plasma (LTAP) for bactericidal efficacy of Gram-negative bacteria (Pseudomonas aeruginosa) with different carrier gases (argon, helium, and nitrogen) using the quality by design (QbD) approach, design of experiments (DoE), and response surface graphs (RSG) is presented. Box-Behnken design was used as the DoE to narrow down and further optimize the experimental factors of LTAP. Plasma exposure time, input DC voltage, and carrier gas flow rate were varied to examine the bactericidal efficacy using the zone of inhibition (ZOI). A higher bactericidal efficacy was achieved under the optimal bactericidal factors having ZOI of 50.837 ± 2.418 mm 2 with the plasma power density of 132 mW/cm 3 for LTAP-Ar at 61.19 s, 14.8747 V, and 219.379 sccm than LTAP-He and LTAP-N 2 . The LTAP-Ar was further evaluated at different frequencies and probe lengths to achieve a ZOI of 58.237 ± 4.01 mm 2 .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.